Diazoxide Choline + Mao Inhibitors Interaction
Moderateinteraction on record
Description
Concomitant use increases diazoxide exposure, which may increase frequency and/or severity of adverse reactions. Dosage reduction of VYKAT XR recommended.
Mechanism
VYKAT XR is a CYP1A2 substrate; strong CYP1A2 inhibitors decrease diazoxide metabolism
Source: NLP:diazoxide choline